SARAH SIAK: Open Payments
NPI 1285624726 · KISSIMMEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,132 in 151 payments from 21 companies in 2025. Trend: 2023 $1,809 · 2024 $3,750 · 2025 $3,132
Food & beverage: $3,127Education: $5
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $487 |
| Novartis Pharmaceuticals Corporation | 25 | $464 |
| GENZYME CORPORATION | 12 | $338 |
| LEO Pharma Inc. | 10 | $277 |
| UCB, Inc. | 9 | $206 |
| Galderma Laboratories, L.P. | 15 | $162 |
| Regeneron Healthcare Solutions, Inc. | 8 | $155 |
| Lilly USA, LLC | 6 | $134 |
| Janssen Biotech, Inc. | 6 | $119 |
| Amgen Inc. | 5 | $118 |
Products named: DUPIXENT, SKYRIZI, ADBRY, Bimzelx, RINVOQ, NEMLUVIO, TREMFYA, OTEZLA.
Industry payments across FL — which companies pay providers there.
